热门资讯> 正文

Medicus Pharma Ltd. reports Q2 results

2025-08-22 01:51

Medicus Pharma Ltd. press release (NASDAQ:MDCX): Q2 Net loss for the second quarter was $6.2 million compared to $3.6 million for the same period in 2024.
Cash and cash equivalents were $9.7 million at the end of the second quarter compared to $4.0 million at the end of the first quarter.

More on Medicus Pharma Ltd.

Medicus Pharma: High-Risk, But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment
Medicus Pharma to acquire Antev
Medicus Pharma prices $7 million share offering
Seeking Alpha’s Quant Rating on Medicus Pharma Ltd.
Historical earnings data for Medicus Pharma Ltd.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。